Confirmed tuberculosis cases that are drug-resistant versus
drug-susceptible, World, 2019
Some tuberculosis patients have bacteria that can die with the standard antibiotic treatment, rifampicin, while others do not. Thisshows the number of tuberculosis cases whose bacteria are confirmed to be susceptible to rifampicin, versus those have beenconfirmed to be drug-resistant. Only a fraction of tuberculosis cases have their bacteria tested to confirm whether they aresusceptible or resistant to drugs.
Choose a country or region
Sort by
Name
Interactive visualization requires JavaScript
Related research and data
Charts
- Average cost of multi drug-resistant tuberculosis treatment
- Average cost of tuberculosis treatment by type
- Causes of deathIHME
- Death rate from respiratory infectionsIHME, crude
- Death rate from respiratory infectionsIHME, age-standardized
- Deaths from respiratory infections
- Expected funding for tuberculosis versus required budget
- Global tuberculosis incidence rate, by age
- Incidence and prevalence of extensively drug-resistant tuberculosis
- Incidence of tuberculosisIHME
- Multidrug-resistant tuberculosis cases
- New cases of tuberculosis with uncertainty intervals
- Number of deaths from tuberculosisIHME
- Number of deaths from tuberculosis and other diseases in people with HIV/AIDS
- Number of newborns who are not vaccinated against tuberculosis
- Number of one-year-olds who have received different vaccinations
- Number of people living with tuberculosis by drug susceptibility
- Number of people with extensively drug resistant tuberculosis
- Number of people with multidrug-resistant tuberculosis
- Rate of new tuberculosis cases
- Share of newborns vaccinated against tuberculosis
- Share of the population estimated to have prior infection by Mycobacterium tuberculosis
- Share of tuberculosis patients with HIV
- Sites providing rapid tuberculosis diagnostics per million people
- The share of tuberculosis tests that are positive
- Tuberculosis case detection rate
- Tuberculosis case fatality rate
- Tuberculosis cases
- Tuberculosis cases attributable to risk factors
- Tuberculosis cases tested versus confirmed to be rifampicin resistant
- Tuberculosis death rate
- Tuberculosis death rateWHO
- Tuberculosis death rateIHME, age-standardized
- Tuberculosis death rateIHME, crude
- Tuberculosis death rate in people without HIVWHO, crude rate
- Tuberculosis death rate, by ageIHME, by age group
- Tuberculosis deathsWHO 2023
- Tuberculosis deathsWHO GHE
- Tuberculosis deaths by HIV status
- Tuberculosis deaths by region
- Tuberculosis deaths in children under five
- Tuberculosis deaths, by age
- Tuberculosis patients living with HIV receiving antiretroviral therapy
- Tuberculosis patients who tested positive for HIV
- Tuberculosis treatment success rate
- Tuberculosis treatment success rate by type
- Tuberculosis-related deaths among people living with HIV